More and more women of childbearing age are being prescribed GLP-1 medications like Ozempic, Wegovy, Mounjaro, and Zepbound. If you're on one of these drugs and thinking about getting pregnant, or if you've just gotten an unexpected positive test, there are a few important things to understand.
The Clear Guidance
The weight-loss labels (Wegovy, Zepbound, Foundayo) say to stop once a pregnancy is recognized, because weight loss offers no benefit in pregnancy and may harm the baby. The diabetes labels (Ozempic, Mounjaro) say to use the drug in pregnancy only if the benefit is worth the possible risk to the baby. Animal studies raised concerns (see our guide on GLP-1 side effects), and there simply isn't enough human data yet to call them safe for use during pregnancy.
When to Stop Before Conception
If you're planning to get pregnant, current guidance says to stop semaglutide at least 2 months beforehand: it lingers in your system longer than most people realize. The tirzepatide labels set no specific pre-conception gap. The Zepbound label says to stop the drug once a pregnancy is recognized; the Mounjaro label says to use it in pregnancy only if the potential benefit justifies the risk to the fetus. Both report fetal harm in animal studies at clinically relevant exposures, so agree a stopping plan with your prescriber before you start trying rather than waiting for a positive test. Your provider may suggest an even longer gap depending on your specific circumstances. (See our semaglutide guide.)
The "Ozempic Baby" Phenomenon
There's been a lot of chatter about surprise pregnancies while on GLP-1 medications, and it's not just anecdotal. Weight loss itself can boost fertility, particularly in women with PCOS or obesity-related ovulation problems. On top of that, two of these drugs can make the birth control pill less effective. Tirzepatide (Zepbound, Mounjaro) says to switch to a non-oral method, or add a barrier method such as condoms, for 4 weeks after you start and for 4 weeks after each dose increase. Foundayo (orforglipron), the daily tablet, says to do the same for 30 days after you start and for 30 days after each dose increase. Foundayo's dose increases come at least 30 days apart, and the later ones depend on how you respond and how well you tolerate the drug, so ask your prescriber when each precaution period applies to you. The semaglutide labels carry no such warning. Foundayo's label says hormonal contraceptives that are not taken by mouth should not be affected, so if you don't want to get pregnant, ask your provider about a non-oral option such as an implant, injection or IUD.
Weight Loss Before Pregnancy
There's a real silver lining here. Losing weight before getting pregnant with the help of GLP-1 medications can actually lead to better pregnancy outcomes. Reaching a healthier weight before conception lowers the risk of gestational diabetes, preeclampsia, and cesarean delivery. Some providers specifically frame GLP-1 therapy as a pre-conception health strategy, lose the weight first, then stop the medication and try to conceive.
After Pregnancy
The labels differ on breastfeeding: Wegovy tablets are not recommended while breastfeeding, the Wegovy injection label says there are no data on whether it passes into breast milk, and the Zepbound label reports undetectable or low levels in breast milk, so it is a decision to make with your provider (read about long-term GLP-1 safety). Evidence about effects on breastfed infants remains limited and differs by medicine and formulation. Discuss your specific treatment with your prescriber. Once you're done nursing, work with your provider to figure out the right time to restart.
What to Do If You Become Pregnant on GLP-1 Medication
If you take Wegovy, Zepbound or Foundayo for weight loss, the labels say to stop once you know you are pregnant, so stop taking it and call your prescriber. If you take Ozempic, Mounjaro or another GLP-1 for type 2 diabetes, call your prescriber that day before you stop, so you have a plan to keep your blood sugar under control. High blood sugar in pregnancy carries its own risks. The labels say there is not enough human data to know the risk from early exposure, and animal studies showed fetal harm at clinically relevant exposures, so your provider will want to monitor the pregnancy more closely.
Find a GLP-1 provider who can help you plan a safe approach to weight loss and family planning, explore options in San Francisco and San Jose.